Eli Lilly and Co’s drug Gemzar should be more widely used to treat advanced breast cancer following a trial in which people taking it and the standard drug paclitaxel lived months longer than those taking paclitaxel alone, a researcher said on Saturday.
Official Title
Conditions
Study Type
Study Design
Further Details
Study Start
Eligibility & Criteria
Total Enrolment
Contact Details
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
Related Articles
Researchers used an experimental molecular therapy in preclinical…
New medical advice is recommending doctors avoid Computed…
Doctors treating children with life-threatening illnesses now have…
Need a health appointment?
Find and book a doctor, dentist, physio and more on Healthengine
Find a practitioner
